University of California San Francisco
Give to UCSF
‘Limitless Potential’ of Artificial Protein Ushers in New Era of ‘Smart’ Cell Therapies
Researchers devised “smart” cells that behave like tiny autonomous robots which may be used to detect damage and disease, and deliver help at just the right time and in just the right amount.
CRISPR Fingers Drug-Resistant Microbes in a ‘FLASH’
A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a new CRISPR-based diagnostic tool, dubbed FLASH, that can rapidly identify any drug-resistant
Synthetic Speech Generated from Brain Recordings
The technology could one day restore the voices of people who have lost the ability to speak due to paralysis and other forms of neurological damage.
‘Virtual Pharmacology’ Advance Tackles Universe of Unknown Drugs
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.
New Drug Could Sustain Oxygen-Starved Hearts
In new studies conducted at UCSF, a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia.
Mutations, Drugs Drive Cancer by Blurring Growth Signals
Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.
Pediatric Device Consortium Celebrates Future Innovations with $6.7M FDA Grant
Thanks to a $6.7 million grant, the newly named UCSF-Stanford Pediatric Device Consortium can focus on the development of revolutionary, low-cost gadgets to diagnose and cure pediatric health conditions.
Researchers Find a New Way to Visualize Integrins
A collaboration between three labs at UCSF has resulted in an unprecedented look at a member of a vital and ubiquitous class of proteins called integrins.
Startup Science
Silicon Valley is helping researchers like Wendell Lim move basic science breakthroughs into translational applications, making treatments available to patients faster than normally possible.
